Canine Myasthenia Gravis: Managing an Autoimmune Neuromuscular Disease

Myasthenia gravis is a serious autoimmune condition affecting the neuromuscular junction in dogs, causing weakness and the life-threatening complication of aspiration pneumonia. Early diagnosis and appropriate management can achieve remission in many cases.

Key Facts

Canine myasthenia gravis (MG) is an autoimmune disease in which antibodies attack acetylcholine receptors at neuromuscular junctions, preventing normal muscle contraction and causing progressive weakness
Acquired MG (the most common form) typically presents in young adult and middle-aged dogs; congenital MG occurs in certain breeds including Jack Russell Terriers and Smooth Fox Terriers from birth
The most common clinical presentation is generalised weakness that worsens with exercise — affected dogs may walk normally for short periods then collapse with profound fatigue, recovering with rest
Megaoesophagus — dilation of the oesophagus due to loss of motility — is a major concurrent condition in approximately 90% of canine MG cases, causing regurgitation of undigested food
Aspiration pneumonia from regurgitation and inhalation is the most common cause of death in MG dogs — management of megaoesophagus and its complications is as important as treating the underlying autoimmune condition
Diagnosis is confirmed by acetylcholine receptor (AchR) antibody titre — a highly specific blood test available at specialist laboratories
Treatment with pyridostigmine (an acetylcholinesterase inhibitor) restores neuromuscular transmission, improving strength; immunosuppression reduces antibody production over time
Spontaneous remission occurs in approximately 50-60% of dogs with acquired MG over 6-18 months; careful long-term management during this period is essential

Welfare Considerations

Myasthenia gravis creates welfare challenges from multiple directions simultaneously. The weakness and fatigue cycle — exercising normally then collapsing, recovering with rest — is frightening and disorienting for affected dogs, who experience sudden, unpredictable loss of muscle control. Megaoesophagus management requires feeding in an upright position (Bailey chair or similar support) for 10-15 minutes after every meal to allow gravity-assisted oesophageal transit — a time-consuming and initially distressing procedure for dogs unused to it. Aspiration pneumonia — food or liquid inhaled into the lungs — causes acute respiratory compromise that is both painful and potentially fatal. The long time horizon to potential remission (6-18 months of intensive management) means sustained owner commitment is essential for welfare. Dogs that tolerate the management regimen well — feeding position, medication twice daily, restricted exercise during relapses — can maintain reasonable quality of life during the management period and achieve lasting remission. The welfare prognosis is substantially better for dogs whose owners can provide the intensive management MG requires.

What You Can Do

Seek specialist referral for any dog with exercise-induced collapse or concurrent megaoesophagus — MG diagnosis requires specific blood testing not available at all practices
Begin Bailey chair or equivalent upright feeding immediately on megaoesophagus diagnosis — this single intervention most significantly reduces aspiration pneumonia risk
Feed small meals 3-4 times daily rather than one or two larger meals — smaller volumes reduce regurgitation risk in megaoesophagus management
Monitor your dog's respiratory rate and character carefully — early detection of aspiration pneumonia (increased respiratory rate, cough, exercise intolerance beyond baseline) enables earlier antibiotic treatment and better outcomes
Restrict exercise to controlled, short activities with extended rest periods — exercise worsens MG weakness and can precipitate crisis episodes
Connect with MG and megaoesophagus owner communities (Dogs with Megaoesophagus Facebook group) — these provide practical guidance on feeding positions, meal preparation, and managing the emotional demands of this complex condition